{"entity":{"type":"insider","cik":"0001569983","url":"/insider/0001569983","json_url":"/insider/0001569983.json","name":"Liu Tony","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":6,"first":"2013-04-17","last":"2020-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Liu Tony","source":"filing","n_filings":6,"first_seen":"2013-04-17","last_seen":"2020-02-13"}],"transactions":[{"id":2380283,"accession":"0001654954-20-001538","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-10","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":15.08,"price_display":"15.08","price_state":"stated","total_value":13195.0,"total_display":"13,195.00","shares_owned_after":247517.0,"shares_owned_after_display":"247,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2020-02-13","scope":"insider"},{"id":2380281,"accession":"0001654954-20-001538","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-9","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":14.68,"price_display":"14.68","price_state":"stated","total_value":12845.0,"total_display":"12,845.00","shares_owned_after":248392.0,"shares_owned_after_display":"248,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-27","filed_date":"2020-02-13","scope":"insider"},{"id":2380278,"accession":"0001654954-20-001538","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-8","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":11.47,"price_display":"11.47","price_state":"stated","total_value":10036.25,"total_display":"10,036.25","shares_owned_after":249267.0,"shares_owned_after_display":"249,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2020-02-13","scope":"insider"},{"id":2380275,"accession":"0001654954-20-001538","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-7","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":11987.5,"total_display":"11,987.50","shares_owned_after":250142.0,"shares_owned_after_display":"250,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2020-02-13","scope":"insider"},{"id":2380270,"accession":"0001654954-20-001538","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-6","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":14.94,"price_display":"14.94","price_state":"stated","total_value":13072.5,"total_display":"13,072.50","shares_owned_after":251017.0,"shares_owned_after_display":"251,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2020-02-13","scope":"insider"},{"id":2380267,"accession":"0001654954-20-001538","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-5","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":14822.5,"total_display":"14,822.50","shares_owned_after":251892.0,"shares_owned_after_display":"251,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2020-02-13","scope":"insider"},{"id":2380263,"accession":"0001654954-20-001538","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-4","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":16.89,"price_display":"16.89","price_state":"stated","total_value":14778.75,"total_display":"14,778.75","shares_owned_after":252767.0,"shares_owned_after_display":"252,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-29","filed_date":"2020-02-13","scope":"insider"},{"id":2380261,"accession":"0001654954-20-001538","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-3","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":14700.0,"total_display":"14,700.00","shares_owned_after":253642.0,"shares_owned_after_display":"253,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-27","filed_date":"2020-02-13","scope":"insider"},{"id":2380257,"accession":"0001654954-20-001538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-2","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":18.06,"price_display":"18.06","price_state":"stated","total_value":15802.5,"total_display":"15,802.50","shares_owned_after":254517.0,"shares_owned_after_display":"254,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2020-02-13","scope":"insider"},{"id":2380255,"accession":"0001654954-20-001538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-20-001538","line_url":"/filing/0001654954-20-001538#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":17.69,"price_display":"17.69","price_state":"stated","total_value":15478.75,"total_display":"15,478.75","shares_owned_after":255392.0,"shares_owned_after_display":"255,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-25","filed_date":"2020-02-13","scope":"insider"},{"id":8432638,"accession":"0001654954-19-001595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001654954-19-001595","line_url":"/filing/0001654954-19-001595#line-3","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":17.64,"price_display":"17.64","price_state":"stated","total_value":15435.0,"total_display":"15,435.00","shares_owned_after":116400.0,"shares_owned_after_display":"116,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2019-02-14","scope":"insider"},{"id":8432634,"accession":"0001654954-19-001595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-19-001595","line_url":"/filing/0001654954-19-001595#line-2","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":18.07,"price_display":"18.07","price_state":"stated","total_value":15811.25,"total_display":"15,811.25","shares_owned_after":117275.0,"shares_owned_after_display":"117,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2019-02-14","scope":"insider"},{"id":8432630,"accession":"0001654954-19-001595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-19-001595","line_url":"/filing/0001654954-19-001595#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":12.75,"price_display":"12.75","price_state":"stated","total_value":11156.25,"total_display":"11,156.25","shares_owned_after":118150.0,"shares_owned_after_display":"118,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-26","filed_date":"2019-02-14","scope":"insider"},{"id":4824234,"accession":"0001654954-17-011879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-17-011879","line_url":"/filing/0001654954-17-011879#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29167.0,"shares_display":"29,167","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":350004.0,"total_display":"350,004.00","shares_owned_after":139167.0,"shares_owned_after_display":"139,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":4362926,"accession":"0001654954-17-005408","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-8","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":19865.0,"total_display":"19,865.00","shares_owned_after":129025.0,"shares_owned_after_display":"129,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362923,"accession":"0001654954-17-005408","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-7","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":14364.0,"total_display":"14,364.00","shares_owned_after":124125.0,"shares_owned_after_display":"124,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362920,"accession":"0001654954-17-005408","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-6","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":13660.0,"total_display":"13,660.00","shares_owned_after":121925.0,"shares_owned_after_display":"121,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362917,"accession":"0001654954-17-005408","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-5","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":8208.0,"total_display":"8,208.00","shares_owned_after":124925.0,"shares_owned_after_display":"124,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362915,"accession":"0001654954-17-005408","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-4","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.81,"price_display":"6.81","price_state":"stated","total_value":5448.0,"total_display":"5,448.00","shares_owned_after":119825.0,"shares_owned_after_display":"119,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362912,"accession":"0001654954-17-005408","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-3","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":5440.0,"total_display":"5,440.00","shares_owned_after":124925.0,"shares_owned_after_display":"124,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362909,"accession":"0001654954-17-005408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-2","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":685.0,"total_display":"685.00","shares_owned_after":124125.0,"shares_owned_after_display":"124,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4362904,"accession":"0001654954-17-005408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001654954-17-005408","line_url":"/filing/0001654954-17-005408#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director, Officer (CEO, CFO)","officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":6.78,"price_display":"6.78","price_state":"stated","total_value":678.0,"total_display":"678.00","shares_owned_after":119925.0,"shares_owned_after_display":"119,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":6976305,"accession":"0001354488-14-003027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-003027","line_url":"/filing/0001354488-14-003027#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-30","scope":"insider"},{"id":4703081,"accession":"0001569983-13-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001569983-13-000002","line_url":"/filing/0001569983-13-000002#line-1","is_derivative":false,"issuer_cik":"0001378624","issuer_name":"Cellular Biomedicine Group, Inc.","issuer_ticker":"CBMG","issuer_name_source":null,"issuer_url":"/issuer/0001378624","owner_cik":"0001569983","owner_name":"Liu Tony","owner_url":"/insider/0001569983","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001378624","name":"Cellular Biomedicine Group, Inc.","url":"/issuer/0001378624","role":"Director, Officer (CEO, CFO)","n_filings":6,"first_seen":"2013-04-17","last_seen":"2020-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001569983","retrieved_at":"2026-08-21T12:02:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}